pentoxifylline has been researched along with Critical Illness in 8 studies
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline (PTX) is a candidate adjuvant medication for the treatment of sepsis and necrotizing enterocolitis in preterm infants." | 7.96 | Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis. ( Berger, A; Kempf, K; Schüller, SS; Strunk, T; Unterasinger, L, 2020) |
| "5 mg/kg per h pentoxifylline continuously for 5 days (after a loading dose of 600 mg) (trauma-PTX, n = 13; sepsis-PTX, n = 13) or saline solution as placebo (trauma-control; n = 13; sepsis-control, n = 13)." | 5.08 | Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient? ( Boldt, J; Heesen, M; Hempelmann, G; Heyn, S; Müller, M, 1996) |
| "Pentoxifylline (PTX) is a candidate adjuvant medication for the treatment of sepsis and necrotizing enterocolitis in preterm infants." | 3.96 | Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis. ( Berger, A; Kempf, K; Schüller, SS; Strunk, T; Unterasinger, L, 2020) |
| "Sepsis is associated with markedly increased plasma concentrations of adhesion molecules, indicating endothelial activation or damage." | 3.78 | Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. ( Boldt, J; Heesen, M; Hempelmann, GG; Muller, M; Neumann, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurul, S | 1 |
| Allegaert, K | 1 |
| Flint, RB | 1 |
| Taal, HR | 1 |
| Schüller, SS | 1 |
| Kempf, K | 1 |
| Unterasinger, L | 1 |
| Strunk, T | 1 |
| Berger, A | 1 |
| Bacher, A | 1 |
| Eggensperger, E | 1 |
| Koppensteiner, R | 1 |
| Mayer, N | 1 |
| Klimscha, W | 1 |
| Castañon-Gonzalez, JA | 1 |
| Eid-Lidt, G | 1 |
| Wacher, N | 1 |
| Gallegos-Perez, H | 1 |
| Miranda-Ruiz, R | 1 |
| Boldt, J | 2 |
| Muller, M | 2 |
| Heesen, M | 2 |
| Neumann, K | 1 |
| Hempelmann, GG | 1 |
| Heyn, S | 1 |
| Hempelmann, G | 1 |
1 review available for pentoxifylline and Critical Illness
| Article | Year |
|---|---|
Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents; Cell Adhesion Molecules; Combined Modality The | 1996 |
4 trials available for pentoxifylline and Critical Illness
| Article | Year |
|---|---|
Pentoxifylline attenuates the increase in whole blood viscosity after transfusion.
Topics: Adult; Aged; Blood Transfusion; Blood Viscosity; Critical Illness; Female; Hematocrit; Humans; Male; | 2005 |
Pentoxifylline and oxygen consumption in severe sepsis--a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; Cardiac Output; Critical | 1995 |
Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents; Cell Adhesion Molecules; Combined Modality The | 1996 |
Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient?
Topics: Adult; Critical Illness; Double-Blind Method; Female; Fibrinogen; Humans; Infusions, Intravenous; Ma | 1996 |
4 other studies available for pentoxifylline and Critical Illness
| Article | Year |
|---|---|
Influence of Different Volume Therapies and Pentoxifylline Infusion on Circulating Soluble Adhesion Molecules in Critically Ill Patients: Retraction.
Topics: Critical Illness; Humans; Pentoxifylline | 2023 |
Influence of Long-Term Continuous Intravenous Administration of Pentoxifylline on Endothelial-Related Coagulation in Critically Ill Patients: Retraction.
Topics: Administration, Intravenous; Critical Illness; Humans; Pentoxifylline | 2023 |
"How can a drug to treat claudication in adults save preterm newborns?"
Topics: Critical Illness; Enterocolitis, Necrotizing; Humans; Infant; Infant, Newborn; Infant, Premature; Pe | 2020 |
Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis.
Topics: Critical Illness; Drug Administration Schedule; Enterocolitis, Necrotizing; Female; Humans; Infant, | 2020 |